about
GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI B...
Read More
0.22
-0.06
(-21.43%)
5.0M
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
GRI Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..